v3.26.1
Consolidated Statements of Cash Flows
$ in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2025
USD ($)
Dec. 31, 2025
HKD ($)
Dec. 31, 2024
HKD ($)
Dec. 31, 2023
HKD ($)
Cash flows from operating activities        
Net loss $ (5,059) $ (39,353) $ (5,523) $ (6,014)
Adjustment:        
Depreciation and amortization 251 1,951 350 8
Gain on bargain purchase (3)
Share of losses of associate 6 43
Impairment on investment under equity method 501 3,900
Provision for (reversal of) allowance for expected credit losses, net 242 1,881 (1,403) 10,944
Changes in operating assets and liabilities:        
Loans to customers (5,954) (46,338) 20,003 11,104
Receivables from customers and broker-dealers 79 614 10,525 (7,812)
Prepaid expenses and other current assets (2,020) (15,721) 248 (26)
Income taxes recoverable 22 171 (692)
Deferred tax assets 397 3,087 (982) (1,791)
Refundable deposits (4) (28) (218)
Payables to customers and clearing organizations 1,339 10,420 (30,501) 5,670
Accruals and other current liabilities 105 817 1,228 (831)
Accrued commission expenses (54) (418) 42 (1,714)
Lease liability (150) (1,169)
Income taxes payable (1,165) 664
Cash generated from (used in) operating activities (10,299) (80,146) (8,088) 10,202
Cash flows from investing activities        
Acquisition of subsidiaries 2
Advance to related parties (4) (25)
Repayment from related parties 48 375
Purchase of property, plant and equipment (5) (37)
Purchase of intangible asset (429) (3,340)
Purchase of investment under equity method (835) (6,500) (1,300) (19)
Cash used in investing activities (1,225) (9,525) (1,300) (19)
Cash flows from financing activities        
Loan from related parties 771 6,000
Deferred IPO cost (1,052) (161)
IPO proceed 7,734 60,176
Proceed from private offering 2,094 16,302
(Advance to) repayment from related parties 494 (7,013)
Cash (used in) generated from financing activities 10,599 82,478 (558) (7,174)
Net change in cash, cash equivalents and cash segregated for regulatory purpose (925) (7,193) (9,946) 3,009
Cash, cash equivalents and cash segregated for regulatory purpose at beginning of the year 5,215 40,587 50,533 47,524
Cash and cash equivalents and cash segregated for regulatory purpose at the end of the year 4,290 33,394 40,587 50,533
Supplementary cash flows information        
Cash paid for income taxes (22) (171) (1,727) (69)
Supplemental schedule of non-cash investing and financing activities:        
Dividends made through reduction in amount due from the shareholder (13,322)
Initial recognition of lease obligations related to right-of-use assets 2,208
Reconciliation to amounts on consolidated balance sheets:        
Cash and cash equivalents 1,665 12,963 30,618 12,048
Cash segregated for regulatory purpose 2,625 20,431 9,969 38,485
Total cash, cash equivalents and cash segregated for regulatory purpose $ 4,290 $ 33,394 $ 40,587 $ 50,533